Salivary: Flow and proteins of the innate and adaptive immunity in the limited and diffused systemic sclerosis

Journal of Oral Pathology and Medicine

Volumn 43, Issue 7, 2014, Pages 521-529

  Knaś, Malgorzata ^a   Zalewska, Anna ^b   Waszkiewicz, Napoleon ^b   Szulimowska, Julita ^b   Dzieciol, Janusz ^b   Sierakowski, Stanislaw ^b   Waszkiel, Danuta ^b  

^a Institute of Health Care   (Poland)

^b MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Lactoferrin; Lysozyme; Peroxidase; Saliva; SIgA; Systemic sclerosis

Indexed keywords

LACTOFERRIN; LYSOZYME; PEROXIDASE; SECRETORY IMMUNOGLOBULIN; ANTINUCLEAR ANTIBODY; CENTROMERE ANTIBODY; SALIVA PROTEIN;

ADAPTIVE IMMUNITY; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIFFUSED SYSTEMIC SCLEROSIS; DISEASE COURSE; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; HUMAN; INNATE IMMUNITY; LIMITED SYSTEMIC SCLEROSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN SALIVA LEVEL; SALIVA ANALYSIS; SALIVA LEVEL; SALIVARY GLAND FUNCTION; SALIVATION; SJOEGREN SYNDROME; SYSTEMIC SCLEROSIS; CASE CONTROL STUDY; COMPARATIVE STUDY; DIFFUSE SCLERODERMA; HEALTH SURVEY; IMMUNOLOGY; LIMITED SCLERODERMA; MIDDLE AGED; PAROTID GLAND; PERIODONTICS; PHYSIOLOGY; SALIVA; SECRETION (PROCESS); SECRETION RATE; SUBMANDIBULAR GLAND;

ADAPTIVE IMMUNITY; ADULT; AGED; ANTIBODIES, ANTINUCLEAR; CASE-CONTROL STUDIES; DMF INDEX; FEMALE; HUMANS; IMMUNITY, INNATE; IMMUNOGLOBULIN A, SECRETORY; LACTOFERRIN; MIDDLE AGED; MURAMIDASE; PAROTID GLAND; PERIODONTAL INDEX; PEROXIDASE; SALIVA; SALIVARY PROTEINS AND PEPTIDES; SCLERODERMA, DIFFUSE; SCLERODERMA, LIMITED; SECRETORY RATE; SJOGREN'S SYNDROME; SUBMANDIBULAR GLAND;

EID: 84904401191     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/jop.12166     Document Type: Article

References (35)

1. Joseph A, Brasington R, Kahl L, et al. Immunologic rheumatic disorders. J Allergy Clin Immunol 2010; 125: S204-15.
2. Mahler M, Fritzler MJ. Epitope specificity and significance in systemic autoimmune diseases. Ann N Y Acad Sci 2010; 1183: 267-87.
3. Wick G, Backovik A, Rabensteiner E, et al. The immunology of fibrosis: innate and adaptive responses. Trends Immunol 2010; 31: 110-9.
4. Rose NR, Mackay IR. The Autoimmune Diseases. San Diego: Elsevier Academic Press, 2006.
5. Andonopoulos AP, Drosos AA, Skopouli FN, et al. Sjögren's syndrome in rheumatoid arthritis and progressive systemic sclerosis. A comparative study. Clin Exp Rheumatol 1989; 7: 203-5.
6. Drosos AA, Andonopoulos AP, Costopoulos JS, et al. Sjögren's syndrome in progressive systemic sclerosis. J Rheumatol 1988; 15: 965-8.
7. Osial TAJ, Whiteside TL, Buckingham RB, et al. Clinical and serologic study of Sjögren's syndrome in patients with progressive systemic sclerosis. Arthritis Rheum 1983; 26: 500-8.
8. Rasker JJ, Jayson MI, Jones DE, et al. Sjögren's syndrome in systemic sclerosis. A clinical study of 26 patients. Scand J Rheumatol 1990; 19: 57-65.
9. Hebbar M, Gillot JM, Hachulla E, et al. Early expression of E-selectin, tumor necrosis factor alpha, and mast cell infiltration in the salivary glands of patients with systemic sclerosis. Arthritis Rheum 1996; 39: 1161-5.
10. Mason GI, Hamburger J, Matthews JB. Mast cells, extracellular matrix components, TGFbeta isoforms and TGFbeta receptor expression in labial salivary glands in systemic sclerosis. Ann Rheum Dis 2000; 59: 183-9.
11. Su H, Baron M, Benarroch M, et al. Altered salivary redox homeostasis in patients with systemic sclerosis. J Rheumatol 2010; 37: 1858-63.
12. Zalewska A, Knaś M, Waszkiewicz N, et al. Salivary antioxidants in patients with systemic sclerosis. J Oral Pathol Med 2014; 43: 61-8.
13. Fernaud S, Evans RW. Lactoferrin-a multifunctional protein with antimicrobial properties. Mol Immunol 2003; 40: 395-405.
14. Callewaert L, Michiels C. Lysozymes in the animal kingdom. J Biosci 2010; 35: 127-60.
15. Ashby MT. Inorganic chemistry of defensive peroxidases in the human oral cavity. J Dent Res 2008; 87: 900-14.
16. Nieuw-Amerongen AV, Bolscher JGM, Veerman ECI. Salivary proteins: protective and diagnostic value in cariology? Caries Res 2004; 38: 247-53.
17. Committee SFSCOTARADATC. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1982; 23: 581-90.
18. Leroy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-5.
19. Nagler RM. Salivary glands and the aging process: mechanistic aspects, health status and medicinal efficacy monitoring. Biogerontology 2004; 5: 223-33.
20. Vitali C, Bombardieri S, Jonsson R, et al. Classification Criteria for Sjögren's syndrome: a revised version of the European criteria proposed by American- European Consensus Group. Ann Rheum Dis 2002; 61: 554-8.
21. Schirmer O. Studien zur physiologie der tranenabsonderung und tranenabfuhr. Arch Opthalmol 1903; 56: 197-221.
22. Zalewska A, Knaś M, Waszkiewicz N, et al. Rheumatoid arthritis patients with xerostomia have reduced production of key salivary constituents. Oral Surg Oral Med Oral Pathol Oral Radiol 2013; 115: 483-90.
23. WHO. Oral Health Surveys: basic methods, 4th edn. Genewa: World Health Organization, 1997.
24. Mansson-Rahemtulla B, Baldone DC, Pruitt KM, et al. Specific assays for peroxidases in human saliva. Arch Oral Biol 1986; 31: 661-8.
25. Mancini G, Carbonara AO, Heremans JF. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 1965; 2: 235-54.
26. Zalewska A, Knaś M, Zendzian-Piotrowska M, et al. Antioxidant profile of salivary glands in high fat diet- induced insulin resistance rats. Oral Dis 2013. doi: 10.1111/odi.12173
27. Inoue H, Ono K, Masuda W, et al. Gender difference in unstimulated whole saliva flow rate and salivary gland sizes. Arch Oral Biol 2006; 51: 1055-60.
28. Pedersen AML, Bardow A, Nauntofte B. Salivary changes and dental caries as potential oral markers of autoimmune salivary gland dysfunction in primary Sjögren's syndrome. BMC Clinical Pathology. 2005; 5: 4.
29. Bennett RM, Kokociński T. Lactoferrin content in peripheral blood cells. Br J Haematol 1987; 39: 509-21.
30. Karolewska A, Konopka T, Pupek M, et al. Antibacterial potential of saliva in children with leukemia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008; 105: 739-44.
31. Weiner D, Khankin EV, Levy Y, et al. Effects of cigarette smoke borne reactive nitrogen species on salivary alpha-amylase activity and protein modification. J Physiol Pharmacol 2009; 60(Suppl. 5): 127-32.
32. Tanida T, Okamoto T, Okamoto A, et al. Decreased excretion of antimicrobial proteins and peptides in saliva of patients with oral candidiasis. J Oral Pathol Med 2003; 32: 586-94.
33. Nagler RM, Klein I, Zarzhevsky N, et al. Characterization of the differentiated antioxidant profile of human saliva. Free Radic Biol Med 2002; 32: 268-77.
34. Qvarnstrom M, Janket S, Jones JA, et al. Salivary lysozyme and prevalent hypertension. J Dent Res 2008; 87: 480-4.
35. Pantelidis P, Southcott AM, Cambrey AD, et al. Activation of peripheral blood mononuclear cells in bronchoalveolar lavage fluid from patients with sarcoidosis: visualization of single cell activation products. Thorax 1994; 49: 1146-51.